Page last updated: 2024-10-24

bone mineralization involved in bone maturation

Definition

Target type: biologicalprocess

The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state. [GOC:bf, GOC:BHF]

Bone mineralization is a complex biological process essential for bone maturation, involving the deposition of calcium phosphate crystals, primarily hydroxyapatite, within an organic matrix composed of collagen and other proteins. This process begins during fetal development and continues throughout life, ensuring the strength and rigidity of bones.

The process starts with the formation of osteoid, an unmineralized matrix produced by osteoblasts, specialized bone-forming cells. Osteoid is mainly composed of type I collagen fibers, which provide a scaffold for mineral deposition.

Mineralization is initiated by the nucleation of hydroxyapatite crystals on specific sites within the collagen fibers. This nucleation is facilitated by various factors, including:

1. **Alkaline phosphatase (ALP):** An enzyme secreted by osteoblasts that hydrolyzes inorganic pyrophosphate, a potent inhibitor of hydroxyapatite formation.
2. **Matrix vesicles:** Small membrane-bound vesicles released from osteoblasts and chondrocytes that concentrate calcium and phosphate ions, creating a favorable environment for crystal nucleation.
3. **Calcium-binding proteins:** Proteins like osteocalcin and bone sialoprotein that bind calcium ions and promote their accumulation.
4. **Growth factors:** Factors like bone morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs) that regulate osteoblast differentiation and activity.

Once the initial crystals form, they grow and coalesce, eventually filling the spaces between collagen fibers. This process involves the continuous delivery of calcium and phosphate ions from the bloodstream to the osteoid.

Simultaneously, osteoclasts, specialized bone-resorbing cells, play a crucial role in bone remodeling by dissolving and removing old or damaged bone tissue. This process involves the release of lysosomal enzymes and acids that break down mineralized bone.

Bone mineralization is tightly regulated by various hormonal and cellular factors, including parathyroid hormone (PTH), calcitriol (vitamin D), and fibroblast growth factor 23 (FGF23). These factors control calcium and phosphate homeostasis, osteoblast and osteoclast activity, and bone remodeling.

In conclusion, bone mineralization is a tightly regulated process involving the deposition of hydroxyapatite crystals within an organic matrix. It is essential for bone maturation and involves the interplay of various cellular and molecular factors.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Phosphoethanolamine/phosphocholine phosphataseA phosphoethanolamine/phosphocholine phosphatase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TCT1]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
2-phenyl-1,2-benzisothiazol-3-(2h)-one2-phenyl-1,2-benzisothiazol-3-(2H)-one: structure given in first source; sulfur analog of ebselen
6-fluoro-2-phenyl-1,2-benzothiazol-3-onebenzothiazoles
2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-onesulfonamide
2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acidsulfonamide
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamidesulfonamide
2-(3-chlorophenyl)-1,2-benzothiazol-3-onebenzothiazoles
2-(4-fluorophenyl)-1,2-benzothiazol-3-onebenzothiazoles